CMS: Share Buy-Back Program - 4th Interim Announcement
April 22, 2024 at 11:19 am EDT
Share
EQS Post-admission Duties announcement: CompuGroup Medical SE & Co. KGaA
/ Share Buy-Back Program - 4th Interim Announcement
Share Buy-Back Program - 4th Interim Announcement
22.04.2024 / 17:17 CET/CEST
Dissemination of a Post-admission Duties announcement transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
CompuGroup Medical SE: Disclosure pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program – 4th Interim Announcement
In the period from April 15, 2024 until and including April 19, 2024, CompuGroup Medical SE & Co. KGaA has bought back an aggregate number of 106,540 shares in CompuGroup Medical SE & Co. KGaA within its share buy-back program which had been announced on March 25, 2024 pursuant to Art. 2 para. 1 Commission Delegated Regulation (EU) No 2016/1052 to start on March 26, 2024.
The aggregate number of shares bought back each day during the period from April 15, 2024 until and including April 19, 2024 as well as the daily volume-weighted average prices for such buy-backs are as follows:
Date
Aggregate volume (number of no-par value shares)
Volume-weighted average price (in EUR, excluding ancillary costs and charges)
April 15, 2024
21,350
29.9373
April 16, 2024
34,343
29.0553
April 17, 2024
10,000
29.2615
April 18, 2024
20,847
29.1385
April 19, 2024
20,000
29.0579
Total:
106,540
29.2682
The aggregate number of shares bought back within the share buy-back program in the period from March 26, 2024 until and including April 19, 2024 amounts to 380,536 shares.
Detailed information about the transactions are published on the company‘s website under https://www.cgm.com/corp_en/company/ir-en/share.html .
The acquisitions of the shares in CompuGroup Medical SE & Co. KGaA were carried out by a credit institution assigned by CompuGroup Medical SE & Co. KGaA exclusively via the Frankfurt Stock Exchange (XETRA trading).
Koblenz, April 22, 2024
CompuGroup Medical SE & Co. KGaA
The general partner
22.04.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com
CompuGroup Medical SE & Co. KGaA is a Germany-based company engaged in the enterprise software development. The Company focuses on providing software solutions to healthcare institutions. The activities are divided into six segments: Ambulatory Software Services (AIS), providing practice management software and medical records; Pharmacy Information Systems (PCS), including integrated clinical, administrative and financial software applications for pharmacies; Hospital Information Systems (HIS), such as laboratory and special care information systems; Communication & Data (C&D), offering software interfaces for pharmaceutical and medical equipment manufacturers; provides Picture Archiving and Communication Systems (PACS); Workflow & Decision Support (WDS), delivering software for management support aimed at healthcare payers, such as health insurers and managed care companies, and Internet Service Provider (ISP), providing Internet for healthcare providers.